CLASS I Drug recall · Reported 27 Dec 2023 · FDA Enforcement Report
TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal recalled
Insight Pharmaceuticals is recalling TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, distributed nationwide in the US. The recall was initiated on 22 Nov 2023 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0151-2024
- FDA event ID
- 93449
- Recalling firm
- Insight Pharmaceuticals, Langhorne, PA
- Classification
- Class I
- Status
- Completed
- Recall initiated
- 22 Nov 2023
- FDA classified
- 15 Dec 2023
- Reported
- 27 Dec 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Benzene
Timeline
| 22 Nov 2023 | Recall initiated by company | |
| 15 Dec 2023 | Classified by FDA | +23 days |
| 27 Dec 2023 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Chemical Contamination; presence of benzene.
Product as listed by the FDA
TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591, UPC 363736532611.
Where it was distributed
Nationwide and Puerto Rico
Questions about this recall
Why was it recalled?
Chemical Contamination; presence of benzene.
Which lots are affected?
Lot #s: 0H88645, Exp 07/31/2024; 0B88345, Exp 02/29/2024.
Where was it sold?
Nationwide and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.